AK-IN-1是一种选择性腺苷激酶 (AK) 抑制剂，对腺苷具有竞争性但对ATP无竞争性。在2、4、10 µM浓度下，该化合物分别抑制86%、87%和89%的AK活性，具有在缺血、炎症及癫痫研究中的广泛应用前景。

ABT702 2HCl is a potent non-nucleoside adenosine kinase inhibitor with IC50 value of 1.7 nM, displaying oral activity in animal models of pain and inflammation.

5-Iodotubercidin is a potent inhibitor (IC50 = 26 nM). It also inhibits nucleoside transporter, CK1, insulin receptor tyrosine kinase, phosphorylase kinase, PKA, CK2 and PKC.